Published in PLoS One on September 26, 2014
Methods to improve rehabilitation of patients following breast cancer surgery: a review of systematic reviews. Breast Cancer (Dove Med Press) (2015) 0.84
Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice. PLoS One (2016) 0.77
Late effects of cancer and cancer treatment-the perspective of the patient. Support Care Cancer (2015) 0.77
The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-"Chemobrain". Aging Dis (2016) 0.75
PET Evidence of the Effect of Donepezil on Cognitive Performance in an Animal Model of Chemobrain. Biomed Res Int (2016) 0.75
Correction: chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications. PLoS One (2015) 0.75
The perceptions of Australian oncologists about cognitive changes in cancer survivors. Support Care Cancer (2016) 0.75
Synthesising qualitative and quantitative evidence: a review of possible methods. J Health Serv Res Policy (2005) 9.26
Conducting a critical interpretive synthesis of the literature on access to healthcare by vulnerable groups. BMC Med Res Methodol (2006) 5.13
Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care. Soc Sci Med (2003) 4.68
Using meta ethnography to synthesise qualitative research: a worked example. J Health Serv Res Policy (2002) 3.42
Conducting a meta-ethnography of qualitative literature: lessons learnt. BMC Med Res Methodol (2008) 2.28
The role of illness perceptions in patients with medical conditions. Curr Opin Psychiatry (2007) 2.06
Evaluating meta-ethnography: systematic analysis and synthesis of qualitative research. Health Technol Assess (2011) 1.87
Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv (2009) 1.81
An essay on an authentic meaning of medicalization: the patient's perspective. ANS Adv Nurs Sci (2003) 1.45
Screening for psychosocial distress: a national survey of oncologists. J Support Oncol (2008) 1.42
A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer (2010) 1.40
Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev (2008) 1.35
Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy. Clin Cancer Res (2012) 1.32
The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study. Breast (2005) 1.32
Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliat Support Care (2007) 1.25
Chemotherapy-related cognitive impairment: the breast cancer experience. Oncol Nurs Forum (2012) 1.18
Cognitive function in breast cancer survivors. Cancer Treat Res (2009) 1.12
'Trying to pin down jelly' - exploring intuitive processes in quality assessment for meta-ethnography. BMC Med Res Methodol (2013) 1.11
Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study. J Clin Nurs (2010) 1.09
Impact of perceived cognitive impairment in breast cancer survivors. Eur J Oncol Nurs (2012) 1.07
Employment and breast cancer: a meta-ethnography. Eur J Cancer Care (Engl) (2011) 1.07
Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients--evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer (2005) 1.04
Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy? J Clin Pharm Ther (2006) 1.04
Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. Eur J Cancer Care (Engl) (2011) 1.00
Either called "chemobrain" or "chemofog," the long-term chemotherapy-induced cognitive decline in cancer survivors is real. J Pain Symptom Manage (2010) 1.00
Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients. Psychooncology (2011) 0.96
Predictors of cognitive decline after chemotherapy in breast cancer patients. J Int Neuropsychol Soc (2009) 0.95
Cognitive dysfunction among cancer survivors. Am J Phys Med Rehabil (2011) 0.92
Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors. Crit Rev Oncol Hematol (2009) 0.91
Chemobrain: a translational challenge for neurotoxicology. Neurotoxicology (2008) 0.89
Psycho-oncology. Harv Rev Psychiatry (2009) 0.88
The relationships of a rationality/antiemotionality personality scale to mortalities of cancer and cardiovascular disease in a community population in Japan. J Psychosom Res (2004) 0.88
Women's perceptions and experiences of severe maternal morbidity--a synthesis of qualitative studies using a meta-ethnographic approach. Midwifery (2013) 0.87
Adjuvant chemotherapy for breast cancer and cognitive impairment. South Med J (2009) 0.87
Cognitive side-effects of adjuvant treatments. Breast (2007) 0.86
Neuropsychological studies in breast cancer: in search of chemobrain. Breast Cancer Res Treat (2008) 0.85
Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Ann Oncol (2012) 0.82
Early breast cancer: diagnosis, treatment and survivorship. Br J Nurs (2012) 0.82
Neurocognitive changes in cancer patients. Semin Oncol Nurs (2004) 0.80
Acknowledging the relevance of cognitive changes in cancer patients: perspectives of oncology practitioners in Asia. J Cancer Surviv (2013) 0.80